Amarantus Bioscience Holdings Inc (AMBS)

[Inoviorulez]

You are correct. Here is what the CEO should have done. Forget about ESS that's not the company's focus. Focus on the main pipeline keep costs down as they don't have money.

Burn money only on main programs like Lympro, Eltoprazine, MANF.

Get rid of of this other junk they added like MS test, ESS, etc.

Company needs to manage cash burn more appropriately. First of all ESS is not even part of their company its a skin substitute -- that falls under dermatology.

This company should work on what it was focused to do Alzheimer's/Parkinson's.

Advance MANF for Alzheimer's/Parkinsons - Instead they are focusing on a rare eye disease retinitis pigmentosa. terrible management decisions is driving this down the hole.

Just watching from the sidelines, good thing I don't own this. I feel really bad for shareholders that have lost a lot of money here to the CEO.